Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Imbruvica
Imbruvica
Bristol-Myers, J&J Upgraded On New Drug Prospects
Investors.com
Tue, 09/29/15 - 10:27 pm
Bristol-Myers Squibb
JNJ
Imbruvica
Opdivo
daratumumab
AbbVie edges closer to Imbruvica deal payoff with another FDA filing
Fierce Pharma
Tue, 09/15/15 - 03:16 pm
AbbVie
Imbruvica
FDA
JNJ
CLL
chronic lymphocytic leukemia
AbbVie could end up sidestepping lost sales tied to an expiring patent on Humira in 2017
Motley Fool
Sun, 08/23/15 - 11:40 am
AbbVie
Humira
patents
Imbruvica
autoimmune disease
Chi-Med Arthritis Drug Spurs Interest From Possible Partners
Bloomberg
Fri, 06/19/15 - 10:06 am
Chi-Med
HMPL-523
rheumatoid arthritis
Imbruvica
AbbVie
FDA panel recommends unblinding study after Imbruvica shows clear benefit
Yahoo/Reuters
Tue, 03/17/15 - 08:17 am
FDA
advisory panels
Imbruvica
Pharmacyclics
JNJ
AbbVie
Just where does AbbVie expect to find $7B in Imbruvica sales?
Fierce Pharma Marketing
Tue, 03/10/15 - 01:21 pm
AbbVie
Imbruvica
M&A
Pharmacyclics
Investors Bet $100,000 Cancer Drug Prices Are Here to Stay
Bloomberg
Mon, 03/9/15 - 12:26 pm
drug pricing
cancer
Keytruda
Opdivo
Imbruvica
It's A Drug! It's A Pipeline! It's A New Blockbuster Model!
Forbes
Fri, 03/6/15 - 08:33 am
Pharmacyclics
AbbVie
M&A
Imbruvica
Inside the $21 Billion War for a Blockbuster Cancer Drug
Yahoo/Bloomberg
Fri, 03/6/15 - 07:53 am
AbbVie
Pharmacyclics
M&A
Imbruvica
JNJ
Did AbbVie Just Grossly Overpay for Pharmacyclics Inc.?
Motley Fool
Thu, 03/5/15 - 09:38 am
AbbVie
Pharmacyclics
M&A
Imbruvica
J&J Said to Agree to Acquire Pharmacyclics for Cancer Drug
Bloomberg
Wed, 03/4/15 - 06:01 pm
JNJ
M&A
Pharmacyclics
Imbruvica
J&J-Pharmacyclics drug shows potential in high-risk leukemia patients
Yahoo/Reuters
Tue, 02/17/15 - 12:46 pm
JNJ
Pharmacyclics
Imbruvica
chronic lymphocytic leukemia
FDA expands use of Imbruvica to treat rare form of blood cancer
Yahoo/Reuters
Thu, 01/29/15 - 07:19 pm
FDA
Imbruvica
JNJ
Pharmacyclics
blood cancer
Waldenstrom's Macroglobulinemia
Imbruvica performs well in high-risk leukemia patients
Seeking Alpha
Mon, 01/5/15 - 04:10 pm
Imbruvica
CLL
chronic lymphocytic leukemia
Pharmacyclics
IMBRUVICA® (ibrutinib) Data Suggests Promise in Multiple Myeloma
Yahoo/PR Newswire
Sun, 12/7/14 - 09:57 am
Imbruvica
Multiple Myeloma
Janssen
Pharmacyclics
Bristol-Myers, Pharmacyclics And Janssen Collaborate On OPDIVO And IMBRUVICA
RTT News
Mon, 10/13/14 - 10:14 am
Bristol-Myers Squibb
Pharmacyclics
Janssen
Opdivo
Imbruvica
Gilead’s Zydelig And Johnson & Johnson-Pharmacyclic’s Imbruvica Fighting To Lead Anti-Cancer Drug Race
Bidness Etc.
Mon, 09/22/14 - 08:37 am
Gilead Sciences
JNJ
Pharmacyclics
Imbruvica
Zydelig
Most popular news headlines for Friday, August 1 2014
CP Wire
Sat, 08/2/14 - 09:35 am
Sanofi
Pharmacyclics
layoffs
Jardiance
Imbruvica
Eli Lilly
diabetes
Boehringer Ingelheim
Amgen
Most popular news headlines for Friday, August 1 2014
Sat, 08/2/14 - 09:32 am
Sanofi
Pharmacyclics
layoffs
Jardiance
Imbruvica
Eli Lilly
diabetes
Boehringer Ingelheim
Amgen
The Best Blood Cancer Drug Launch Ever?
Forbes
Fri, 08/1/14 - 10:27 am
Pharmacyclics
Imbruvica
leukemia
Pages
« first
‹ previous
1
2
3
4
5
6
7
next ›
last »